Quick Takeaways
- This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 08 Sep 2025, 18:15.
Stephen Feider - 05 Sep 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)
- Signature
- /s/ Stephen Feider
- Issuer symbol
- BBNX
- Transactions as of
- 05 Sep 2025
- Net transactions value
- -$1,590
- Form type
- 4
- Filing time
- 08 Sep 2025, 18:15:04 UTC
- Previous filing
- 04 Sep 2025
- Next filing
- 09 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 08 Sep 2025."
What Changed
- Previous filing in this sequence was filed on 04 Sep 2025.
- Current net transaction value: -$1,590.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Feider Stephen | Chief Financial Officer | C/O BETA BIONICS, INC., 11 HUGHES, IRVINE | /s/ Stephen Feider | 08 Sep 2025 | 0002048588 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBNX | Common Stock | Options Exercise | $510 | +100 | +0.23% | $5.10 | 44,141 | 05 Sep 2025 | Direct | |
| transaction | BBNX | Common Stock | Sale | $2,100 | -100 | -0.23% | $21.00 | 44,041 | 05 Sep 2025 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBNX | Employee Stock Option (right to buy) | Options Exercise | $0 | -100 | -0.1% | $0.000000 | 99,595 | 05 Sep 2025 | Common Stock | 100 | $5.10 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. |
| F2 | The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |